Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,230 total articles
Vistra (VST) appears to be experiencing a headline-driven retreat rather than a fundamental slowdown. Power contracts and cash flow remain intact, but accounting line items tied to asset closure and decommissioning can compress reported earnings and spook short-term holders. This trade targets a mean reversion back above the 50-day SMA with a clear…
NIQ Global Intelligence is converting solid free cash flow into a cleaner earnings profile. The setup today favors a long trade: entry at $17.40, stop at $15.50 and a $21.00 target over a 180-trading-day window, betting on continued margin expansion and client spend resilience.
Franco-Nevada (FNV) offers exposure to gold and other commodities through a large, diversified royalties and streams portfolio. The stock trades near 52-week highs after a 16% dividend bump and board succession news; fundamentals (free cash flow of $340.5M, market cap ~$51B) point to durable cash conversion but also very rich multiples. This trade …
Unilever (UL) is a diversified consumer staples compounder with a 3.27% yield, stable cash flow, and exposure to growing personal care and hygiene markets. The stock is trading close to near-term technical support (SMA50/$65.64 area) after recent firmness in fundamentals and category tailwinds. This trade idea outlines a buy-on-weakness entry, expl…
Aura Biosciences is a clinical-stage oncology name with a liquid balance sheet and a stock that’s acting like a moving target. Shares are drifting near the mid-$5s with bullish MACD momentum, while short interest remains elevated with a high days-to-cover. This trade idea leans long for a tactical move higher, using tight risk controls and well-def…
Ferguson is a plumbing and HVAC distribution leader with strong profitability metrics and a chart that’s acting like institutions are accumulating shares again. With housing still choppy, the cleaner near-term pitch is non-discretionary repair-and-maintain plus infrastructure-related demand. The trade: buy strength above the short-term trend, targe…
Globant has materially outperformed off the 2025 low, but it is still far below its prior 52-week high. With price back above key moving averages, RSI in the middle of the range, and MACD in bullish momentum, the setup favors a tactical long with tight risk. The bull case hinges on renewed confidence in AI-led services demand and execution, while t…
PacBio (PACB) is acting like a classic early-turnaround chart: higher highs into a fresh 52-week peak, then a sharp dip back toward near-term support. With price sitting around $2.47 and key moving averages rising, the setup is simple: bulls need to defend the $2.40 area and reclaim recent highs to confirm a breakout attempt. The fundamental narrat…
Prosperity Bancshares (PB) just took a hard leg down, but the selloff is starting to look like a valuation and positioning event more than a broken-business story. With PB trading under book (0.90x P/B), a 3.21% dividend yield, and a washed-out RSI near 35, the setup favors a defined-risk long that targets a mean reversion back toward the low-$70s.…
Palantir’s selloff has pushed shares to $160.88 with oversold technicals, but the valuation is still extreme: roughly $383B market cap, ~101x sales, and ~388x earnings. This trade idea focuses on valuing “elite growth” using a simple expectations framework, then pairing it with a defined-risk plan into the 02/02/2026 earnings catalyst. Setup favors…
Progressive has been treated like margins are about to roll over, but the stock is already pricing in a meaningful cooling. With PGR near the low end of its 52-week range, a reasonable P/E around 11x, and improving technical momentum off recent lows, the risk-reward looks skewed to the upside. This is a mid-term trade idea focused on a rebound towa…
Safe Bulkers (SB) is a dry bulk shipper riding a steady uptrend, now pressing into its prior 52-week high zone. With price above key moving averages, bullish MACD momentum, and valuation support from a sub-1 price-to-book, the stock looks like a pragmatic long trade as long as it holds support. This is a defined-risk, mid-term momentum idea with a …
AppLovin has been volatile, but the underlying story is still about Axon turning ad targeting and monetization into a scalable growth engine. With APP down from its $745.61 52-week high and momentum still bearish, this is not a “buy and forget” moment. It is a tactical long trade: lean on the recent lows for risk control and target a rebound toward…
Telos has quietly pushed back into an uptrend as momentum indicators flip bullish and the stock reclaims key moving averages. With a sub-$500M market cap, improving short-interest dynamics, and visible expansion in its TSA PreCheck enrollment footprint, TLS looks like a mispriced small-cap security services name. This is a mid-term trade idea targe…
Antofagasta (ANFGF) is setting up as a tradable long as metals sentiment stays constructive. The stock is holding above key moving averages with bullish MACD momentum and an RSI in the low 60s - strong, but not blow-off. Short interest is sizable versus average volume, which can add fuel to upside continuation if buyers keep pressing. This trade id…
Cheniere Energy (LNG) sits at the intersection of global LNG demand and rising electricity load growth tied to data centers and AI. The stock is pushing higher with bullish MACD and a mid-60s RSI, and the fundamentals screen well: about $45.0B market cap, ~11.4x P/E, EV/EBITDA ~7.9x, and $2.22B of free cash flow. This trade idea looks to ride a con…
Tilray has already absorbed the hype cycle, the dilution fears, and the post-rally hangover. With a sub-$1B market cap, price-to-book around 0.62, manageable leverage, and multiple near-term catalysts tied to medical expansion and U.S. policy momentum, TLRY is shaping into a defined risk/reward long trade. The plan is to buy near current levels, le…
Harley-Davidson shares are hovering near 52-week lows around $20 despite single-digit valuation multiples, a 3.6% dividend yield, and meaningful free cash flow. Meanwhile, short interest remains elevated with roughly 5.7 days-to-cover, creating a market structure where any incremental catalyst can force repositioning. This trade idea outlines a mid…
Applied Digital is trading like a levered AI data-center proxy, but Nvidia’s $2B investment into CoreWeave changes the risk calculus in a way the tape is still digesting. With APLD at fresh 52-week highs and momentum still bullish, the trade is to buy the pullback with defined risk, aiming for a continuation move while respecting that valuation and…
TRX Gold is acting like a stock the market has decided to re-rate. With shares printing a new 52-week high at $1.79 and trading far above key moving averages, the technical setup is strong, but stretched. The fundamental story revolves around the Buckreef Gold Project in Tanzania and management’s push to scale production and improve economics. This…
Ondas has morphed from a sleepy industrial wireless story into an autonomy and defense-adjacent drone platform narrative. The market is rewarding that transition, but the setup still looks like it’s in the early innings: price is holding above key moving averages, volume remains unusually elevated, and sentiment catalysts keep landing. This trade i…
IonQ is a high-volatility quantum name, but it’s also the one leaning hardest into vertical integration after its $1.8B SkyWater deal. Quantum Computing Inc. (QUBT) is the same “quantum” headline trade with far thinner fundamentals and extreme valuation optics (per widely-circulated commentary). This pair trade aims to stay invested in the theme wh…
Orion Group Holdings (ORN) has quietly moved into a better financial posture, with low leverage and solid liquidity, just as contract awards continue to stack up. The stock is trending above key moving averages with bullish MACD momentum, setting up a mid-term breakout retest trade. This is a long trade idea with defined entry, stop, and target lev…
F.N.B. Corp. is trading like a plain-vanilla regional bank, but the business mix (banking plus wealth and insurance) and its footprint across seven states and D.C. give it more ways to win as the rate cycle evolves. With shares near $17.39, FNB sits below its recent $18.30 high while valued at roughly 0.92x book and about 11-12x earnings. This trad…
Roche’s CT-388 obesity data is good enough to matter and, more importantly, good enough to keep investors paying attention as Phase 3 ramps. But the stock is pressing fresh 52-week highs with an overbought RSI, which makes the risk-reward poor if you chase. The trade: wait for a pullback toward moving-average support, then look for a swing entry wi…
